H.C. Wainwright analyst Mitchell Kapoor downgraded Evommune Inc (NYSE: EVMN) from Buy to Neutral.The analyst comments "CSU primary endpoint failure ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE